For example, a study in Italy reported that the excessive prescription of SMBG strips contributed to cost overruns and resulted in some patients, particularly those with insulin-treated diabetes, not receiving a sufficient number of strips to adequately monitor their blood glucose levels [22]. The gene discussed is INS; the disease is diabetes mellitus.